Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

TETRAPHASE PHARMACEUTICALS INC (TTPH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Jul-07-13
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:          
Total revenue  7.418.99.75.111.79.110.5124.9
            Total revenue growth  -61.0%95.6%87.9%-56.0%28.4%-13.2%38.0% 
Expenses:          
Cost of revenue          
Research and development  22.854.9101.763.873.861.931.5 
Selling, general and administrative  49.037.123.7     
    Total expenses  74.992.2125.483.094.774.938.7 
    Loss from operations  -67.5-73.3-115.7-77.8-83.0-65.8-28.2 
            Operating margin  -915.6%-387.6%-1197.1%-1512.7%-710.2%-722.9%-268.8% 
   
Other income and expenses          
Other income  0.3       
Interest income  1.31.71.0  0.00.0 
Interest expense  -2.6-0.6   -1.0-1.7 
    Net loss  -70.1-72.2-114.8-77.5-83.2-66.7-29.6 
   
Net loss per share-basic and diluted  ($22.85)($27.48)($2.63)($2.11)($2.36)($2.49)($1.78) 
   
Weighted-average number of common shares used in net loss per share-basic and diluted  3.12.643.636.735.326.816.7 
    Comprehensive loss  -70.1-72.2-114.8-77.5-83.2-66.7-29.6 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy